Nettet16. des. 2024 · Real-world incidence rates of in-stent restenosis (ISR) account for 12% of PCI. ... In-Stent Restenosis in the Drug-Eluting Stent Era. J Am Coll Cardiol 2010; 56:1897–907. 3. Bhatt D. Treatment of In-Stent Restenosis, Excerpt from Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease. Nettet21. aug. 2024 · In CAS patients with untreated asymptomatic > 70% restenosis, the rate of ipsilateral stroke was extremely low (0.8% over 50 months). CEA patients with untreated, asymptomatic > 70% restenosis had a higher rate of ipsilateral stroke but it was only 5% at 37 months. 6 Another large randomized, controlled trial also reported …
In-Stent Restenosis - an overview ScienceDirect Topics
NettetPredictors of In-Stent Restenosis. × Close Log In. Log in with Facebook Log in with Google. or. Email. Password. Remember me on this computer. or reset password. Enter the email address you signed up with and we'll email you a reset link. Need an account? Click here to sign up. Log In Sign Up. Log ... NettetNational Center for Biotechnology Information methodology business plan
Coronary in-stent restenosis: Current status and future strategies
Nettet10. apr. 2024 · Background: Although use of drug-coated balloons (DCB) is a promising technique, little is known about the clinical efficacy of the Dissolve DCB in drug-eluting … Nettet16. jan. 2002 · In this diverse patient group, restenosis rates were reduced (8% vs. 39%, p = 0.012) with similar effects across the radiation doses (84). A 32 P-β-emitting stent implanted for 91% to 93% de novo lesions at a number of doses reduces intrastent ISR at six months but is associated with high rates of stent-edge restenosis—the so-called … Nettet16. des. 2024 · Clinical restenosis is less common than angiographic restenosis with rates of ≤5% and 10% after 12 months for newer generation drug-eluting stents 1,2. … how to add link in microsoft excel